SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards. CiteAb accelerates ...

NEWARK, Del., June 7, 2023 /PRNewswire/ -- Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune ...

The innovative development of biopharmaceuticals relies on stable, legally compliant R&D tools. Functional cell lines serve as a versatile vital engine driving full-cycle breakthroughs in innovative ...

BASEL, Switzerland, March 30, 2023 /PRNewswire/ -- ACROBiosystems has begun to narrow its focus into helping accelerate the process between preclinical, clinical and commercialization. With over 10 ...

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, the ...

- Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization Rosanna Zhang, Vice President of ACROBiosystems, discussed innovative uses of organoids ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Get an overview of the most important figures from each Acrobiosystems financial report, including the income statement, balance sheet and cash flow statement, along with key financial ratios. Compare ...